KSPHF:OTCMKTS
Kissei Pharmaceutical Co Ltd
US$Â 24.50
0.00%
(0.00) Siku 1
1 Okt, 10:21:43 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya KSPHF...
Mtaji wa soko
176.16B
Wastani wa kiasi cha mauzo
20.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
US$Â 31.90
Chini kwa wiki 52
US$Â 24.50
Beta
13.94
Hisa za wawekezaji
46.54M
Idadi ya wafanyakazi
elfu 2
Mtaji wa soko
176.16B
Wastani wa kiasi cha mauzo
20.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
US$Â 31.90
Chini kwa wiki 52
US$Â 24.50
Beta
13.94
Hisa za wawekezaji
46.54M
Idadi ya wafanyakazi
elfu 2
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
The Daily News | Texas' Oldest Newspaper
·
dakika 42 zilizopita
A screen shows the logo and a ticker symbol for The Walt Disney Company on the floor of the New York Stock Exchange (NYSE) in New York
CoinDesk
·
saa 1 iliyopita
Bitcoin rebounds above $83,000 as it decouples from tumbling Korean stocks and Nasdaq futures
MarketBeat
·
dakika 22 zilizopita
Wall Street Zen Upgrades Radware (NASDAQ:RDWR) to Buy
Wasifu
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
Difelikefalin
Fostamatinib
Linzagolix
Mitiglinide
Remogliflozin etabonate
Silodosin
Tranilast
In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immunotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China. Wikipedia
Kuhusu Kissei Pharmaceutical Co Ltd
Afisa Mkuu Mtendaji (CEO)Mutsuo Kanzawa
Wafanyakazielfu 1.79
Lilianzishwa9 Ago 1946
Makao makuuMatsumoto, Mkoa wa Nagano, Japani
Sekta-
Tovutikissei.co.jp